SI
SI
discoversearch

We've detected that you're using an ad content blocking browser plug-in or feature. Ads provide a critical source of revenue to the continued operation of Silicon Investor.  We ask that you disable ad blocking while on Silicon Investor in the best interests of our community.  If you are not using an ad blocker but are still receiving this message, make sure your browser's tracking protection is set to the 'standard' level.
Biotech / Medical : Neurogen (NRGN) -- Ignore unavailable to you. Want to Upgrade?


To: dr.praveen who wrote (446)12/27/2006 3:30:14 PM
From: tuck  Read Replies (1) | Respond to of 523
 
Speaking of Aplindore for RLS, here's a nice overview of the condition, and available treatments for it. Looks at the various dopamine receptor agonists (among other classes) and their side effects:

emedicine.com

Cheers, Tuck



To: dr.praveen who wrote (446)2/8/2007 12:33:37 PM
From: tuck  Read Replies (1) | Respond to of 523
 
Any thoughts about Aplindore versus XP13512, which is hot stuff today? I haven't looked closely at the latter, yet; had XNPT on a watch list but hadn't done any DD.

Congrats if you're holding some.

Cheers, Tuck